Literature DB >> 12389865

Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey.

Kaija Kuurila1, Ilkka Kaitila, Reijo Johansson, Reidar Grénman.   

Abstract

Hearing loss, bone fragility, and blue sclerae are the principal clinical features in osteogenesis imperfecta (OI), a genetic disorder of connective tissue. In a nationwide search, an audiometric evaluation of 133 adult patients was performed. According to the criteria introduced by Sillence, type I was the most common form of OI. Of the patients with normal hearing on audiometry, 17.1% reported subjective hearing loss, and 19.1% of the patients with impaired hearing did not recognize it. On audiometry, 57.9% of the patients had hearing loss, which was progressive, often of mixed type, and mostly bilateral, and began in the second to fourth decades of life. The frequency or severity of the hearing loss was not correlated with any other clinical features of OI. Hearing loss is common, affecting patients with all types of OI. Subjective misjudgment of hearing ability supports the need for repeated audiometry in all OI patients. A baseline study at the age of OI years followed by audiograms every third year thereafter is recommended.

Entities:  

Mesh:

Year:  2002        PMID: 12389865     DOI: 10.1177/000348940211101014

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  25 in total

1.  The potential research impact of patient reported outcomes on osteogenesis imperfecta.

Authors:  Catherine A Brownstein; Paul Wicks
Journal:  Clin Orthop Relat Res       Date:  2010-10       Impact factor: 4.176

2.  Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.

Authors:  M Hijazi; S D Mihailescu; J Horion; A Goldenberg; J P Marie
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-12       Impact factor: 2.503

3.  Osteogenesis Imperfecta and Extra-/Intradural Hematomas: A Case Report and Review of the Literature.

Authors:  Fatih Yakar; Emrah Celtikci; Onur Ozgural; Umit Eroglu; Yusuf Sukru Caglar
Journal:  J Pediatr Genet       Date:  2018-06-14

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

5.  Osteogenesis imperfecta and hearing loss: an analysis of patients attended at a benchmark treatment center in southern Brazil.

Authors:  Andressa Colares da Costa Otavio; Adriane Ribeiro Teixeira; Temis Maria Félix; Letícia Petersen Schimidt Rosito; Sady Selaimen da Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-31       Impact factor: 2.503

6.  The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta.

Authors:  Zhen-Lin Zhang; Hao Zhang; Yao-hua Ke; Hua Yue; Wen-Jin Xiao; Jin-Bo Yu; Jie-Mei Gu; Wei-Wei Hu; Chun Wang; Jin-Wei He; Wen-Zhen Fu
Journal:  J Bone Miner Metab       Date:  2011-06-14       Impact factor: 2.626

7.  Otopathology in Osteogenesis Imperfecta.

Authors:  Felipe Santos; Andrew A McCall; Wade Chien; Saumil Merchant
Journal:  Otol Neurotol       Date:  2012-12       Impact factor: 2.311

8.  'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia.

Authors:  Sandra Donkervoort; Alice Schindler; Carolina Tesi-Rocha; Allison Schreiber; Meganne E Leach; Jahannaz Dastgir; Ying Hu; Ami Mankodi; Kathryn R Wagner; Neil R Friedman; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2013-08-11       Impact factor: 4.296

Review 9.  Bisphosphonate therapy for osteogenesis imperfecta.

Authors:  Kerry Dwan; Carrie A Phillipi; Robert D Steiner; Donald Basel
Journal:  Cochrane Database Syst Rev       Date:  2016-10-19

10.  Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.

Authors:  J D Hald; L Folkestad; C Z Swan; J Wanscher; M Schmidt; H Gjørup; D Haubek; C-H Leonhard; D A Larsen; J Ø Hjortdal; T Harsløf; M Duno; A M Lund; J-E B Jensen; K Brixen; B Langdahl
Journal:  Osteoporos Int       Date:  2018-08-24       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.